Trial reportTrials2026
Working with underrepresented groups: lessons from the SCHEMA trial.
Trial report in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
There is a growing focus on ensuring research is accessible and inclusive to individuals traditionally not represented. To be truly inclusive, the broader context needs to be explored, as barriers might not only be linked to population characteristics but also to the complexity of their environment, and limited research opportunity within certain healthcare professions. The SCHEMA trial is a randomised controlled trial evaluating whether interpersonal art psychotherapy is effective at reducing aggressive behaviour in individuals with learning disability or borderline intellectual function in secure care. The trial illustrates the challenges and solutions to conducting research in secure care settings, a challenging environment, with an underrepresented patient population and healthcare professionals unfamiliar with conducting research. To better understand the challenges, a survey was circulated to understand site staff's general experience with research and their specific experiences of the SCHEMA trial. Difficulty of balancing research with other responsibilities and a fear of making a mistake were the most common barriers. The top two facilitators were working with collaborators and the presence of clear guidelines and protocols. Site setup was identified as the most challenging stage of the trial, while follow-up data collection was identified as the least challenging. In response to these challenges, the central trial team worked closely with site staff to provide tailored support to address the unique needs of the healthcare professionals and participant population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.